These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22022415)

  • 1. Resource utilization and cost-effectiveness of counselor- vs. provider-based rapid point-of-care HIV screening in the emergency department.
    Walensky RP; Morris BL; Reichmann WM; Paltiel AD; Arbelaez C; Donnell-Fink L; Katz JN; Losina E
    PLoS One; 2011; 6(10):e25575. PubMed ID: 22022415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Counselor- versus provider-based HIV screening in the emergency department: results from the universal screening for HIV infection in the emergency room (USHER) randomized controlled trial.
    Walensky RP; Reichmann WM; Arbelaez C; Wright E; Katz JN; Seage GR; Safren SA; Hare AQ; Novais A; Losina E
    Ann Emerg Med; 2011 Jul; 58(1 Suppl 1):S126-32.e1-4. PubMed ID: 21684391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel emergency department registration kiosk for HIV screening is cost-effective.
    Hsieh YH; Holtgrave DR; Peterson S; Gaydos CA; Rothman RE
    AIDS Care; 2016; 28(4):483-6. PubMed ID: 26477440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department.
    Dowdy DW; Rodriguez RM; Hare CB; Kaplan B
    Acad Emerg Med; 2011 Jul; 18(7):745-53. PubMed ID: 21762236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of HIV Screening in Emergency Departments: Results From the Pragmatic Randomized HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial.
    Haukoos J; Hopkins E; Campbell JD; Lyons MS; Rothman RE; Hsieh YH; White DAE; Trent S; Al-Tayyib AA; Gardner EM; Sabel AL; Rowan SE;
    Ann Emerg Med; 2024 Sep; 84(3):234-243. PubMed ID: 38661620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial.
    Schackman BR; Metsch LR; Colfax GN; Leff JA; Wong A; Scott CA; Feaster DJ; Gooden L; Matheson T; Haynes LF; Paltiel AD; Walensky RP
    Drug Alcohol Depend; 2013 Feb; 128(1-2):90-7. PubMed ID: 22971593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of strategies to improve HIV testing and receipt of results: economic analysis of a randomized controlled trial.
    Sanders GD; Anaya HD; Asch S; Hoang T; Golden JF; Bayoumi AM; Owens DK
    J Gen Intern Med; 2010 Jun; 25(6):556-63. PubMed ID: 20204538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.
    Hyle EP; Jani IV; Lehe J; Su AE; Wood R; Quevedo J; Losina E; Bassett IV; Pei PP; Paltiel AD; Resch S; Freedberg KA; Peter T; Walensky RP
    PLoS Med; 2014 Sep; 11(9):e1001725. PubMed ID: 25225800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmatic cost evaluation of nontargeted opt-out rapid HIV screening in the emergency department.
    Haukoos JS; Campbell JD; Conroy AA; Hopkins E; Bucossi MM; Sasson C; Al-Tayyib AA; Thrun MW;
    PLoS One; 2013; 8(12):e81565. PubMed ID: 24391706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.
    Paltiel AD; Walensky RP; Schackman BR; Seage GR; Mercincavage LM; Weinstein MC; Freedberg KA
    Ann Intern Med; 2006 Dec; 145(11):797-806. PubMed ID: 17146064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs.
    Schackman BR; Leff JA; Barter DM; DiLorenzo MA; Feaster DJ; Metsch LR; Freedberg KA; Linas BP
    Addiction; 2015 Jan; 110(1):129-43. PubMed ID: 25291977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of HIV screening in patients older than 55 years of age.
    Sanders GD; Bayoumi AM; Holodniy M; Owens DK
    Ann Intern Med; 2008 Jun; 148(12):889-903. PubMed ID: 18559840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded screening for HIV in the United States--an analysis of cost-effectiveness.
    Paltiel AD; Weinstein MC; Kimmel AD; Seage GR; Losina E; Zhang H; Freedberg KA; Walensky RP
    N Engl J Med; 2005 Feb; 352(6):586-95. PubMed ID: 15703423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Budget impact analysis of HIV testing in the VA healthcare system.
    Anaya HD; Chan K; Karmarkar U; Asch SM; Bidwell Goetz M
    Value Health; 2012 Dec; 15(8):1022-8. PubMed ID: 23244803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.
    Sanders GD; Bayoumi AM; Sundaram V; Bilir SP; Neukermans CP; Rydzak CE; Douglass LR; Lazzeroni LC; Holodniy M; Owens DK
    N Engl J Med; 2005 Feb; 352(6):570-85. PubMed ID: 15703422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis and HIV screening: the emergency medicine perspective.
    Hsu H; Walensky RP
    Ann Emerg Med; 2011 Jul; 58(1 Suppl 1):S145-50. PubMed ID: 21684394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the integration of HIV self-testing into low-resource health systems: study protocol for a cluster-randomized control trial from EQUIP Innovations.
    Dovel K; Shaba F; Nyirenda M; Offorjebe OA; Balakasi K; Phiri K; Nichols B; Tseng CH; Bardon A; Ngona K; Hoffman R
    Trials; 2018 Sep; 19(1):498. PubMed ID: 30223874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost of implementing rapid HIV testing in sexually transmitted disease clinics in the United States.
    Eggman AA; Feaster DJ; Leff JA; Golden MR; Castellon PC; Gooden L; Matheson T; Colfax GN; Metsch LR; Schackman BR
    Sex Transm Dis; 2014 Sep; 41(9):545-50. PubMed ID: 25118967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness of the 'One4All' HIV Linkage Intervention in Guangxi Zhuang Autonomous Region, China.
    Zang X; Tang H; Min JE; Gu D; Montaner JS; Wu Z; Nosyk B
    PLoS One; 2016; 11(11):e0167308. PubMed ID: 27893864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.